Novel Agents and Future Perspectives on Theranostics
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference58 articles.
1. CD38: A target for immunotherapeutic approaches in multiple myeloma;Morandi;Frontiers in Immunology,2018
2. Daratumumab: first global approval;McKeage;Drugs,2016
3. Preclinical development of CD38-targeted [(89)Zr]Zr-DFO-daratumumab for Imaging multiple myeloma;Ghai;J Nucl Med,2018
4. Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma;Caserta;Blood,2018
5. ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab;Kang;European journal of nuclear medicine and molecular imaging,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases;Nuclear Medicine and Biology;2024-02
2. Molecular imaging of bone metastasis;Journal of Bone Oncology;2023-06
3. Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach;Frontiers in Medicine;2023-01-17
4. Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy;Experimental Hematology & Oncology;2022-11-08
5. Site-Specific Intact N-Linked Glycopeptide Characterization of Prostate-Specific Membrane Antigen from Metastatic Prostate Cancer Cells;ACS Omega;2022-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3